ShanghaiJune 24, 2026 /PRNewswire/ — From August 26-28 in Shanghai, the 2026 11th MMC Medical Market Annual Conference, organized by Siqi Circle, will set sail once again.
As an annual practical event focused on the collaborative innovation of “Medical + Market + Commercialization” in the pharmaceutical industry, this year’s conference, themed “Compliance as the Foundation, Innovation for Value,” will gather industry leaders to explore new pathways for high-quality development in the pharmaceutical sector. Key topics include compliance governance, AI digitalization, medical value innovation, new product launches, omnichannel growth, and full lifecycle patient management.
What kind of conference is this?
The MMC Medical Market Annual Conference is dedicated to creating the most practical learning and exchange platform in the pharmaceutical industry.
Over the past eleven years, the conference has consistently focused on the most critical, urgent, and challenging core issues facing pharmaceutical companies. It prioritizes real-case analysis, cutting-edge trend insights, and actionable experience sharing, helping companies identify opportunities for deterministic growth amid cycles of change.
Whether it’s upgrading the value of medical affairs, innovating market models, breaking through product commercialization, or leveraging AI, patient management, and compliance system development, the MMC Annual Conference strives to provide methodologies and practical pathways that are replicable, actionable, and scalable.
Who participates in MMC?
Previous MMC Annual Conferences have attracted over 50,000 industry professionals cumulatively, covering more than 5,000 pharmaceutical and health-related organizations. The conference targets core functional roles such as medical affairs, marketing, commercialization operations, sales management, digital innovation, market access, patient management, retail business, and omnichannel operations.
The 2025 10th MMC Medical Market Annual Conference brought together diverse ecosystem participants, including multinational pharmaceutical companies, state-owned pharmaceutical enterprises, leading domestic pharmaceutical firms, innovative biotech companies, medical technology companies, internet healthcare platforms, and industry service providers. These included: Merck Sharp & Dohme, Bayer, Bristol-Myers Squibb, Abbott, Daiichi Sankyo, Sanofi, China Resources Double-Crane, Sinopharm Group companies, Tianjin Darentang, Tasly, Hengrui Medicine, Chia Tai Tianqing, Livzon Pharmaceutical, Jingxin Pharmaceutical, Conba, Innovent Biologics, Yinno Pharmaceutical, JD Health, Ant Group, Taimei Medical, Ocean Engine, Jiawei Digital Cloud, and Illuminera CBH, among others.
Professionals from different company types, development stages, and business models can find content and collaboration opportunities tailored to their needs at MMC.
What does MMC discuss?
The first day of the 2025 10th MMC Annual Conference featured four popular breakout forums:
- Omnichannel Forum
- New Product Launch Forum
- Medical Forum
- AI Empowerment: Scientific Research Leap, Discipline Collaboration, and Medical Innovation Forum
Focusing on hot industry topics, speakers highlighted:
- Integrated in-hospital and out-of-hospital omnichannel precision operations practices
- Launch strategies and commercialization pathways for innovative drugs, CGT, and high-value medical devices
- AI-driven medical affairs upgrades and academic marketing innovation
- Differentiation strategies in the context of product homogenization
- Business model innovation under normalized compliance
- Growth opportunities amid the trend of medical consumerization
From trend insights to case analysis, and from strategic thinking to execution methods, MMC consistently prioritizes practical guidance, delivering truly valuable content to the industry.
In 2026, as the pharmaceutical industry undergoes deepening transformation, compliance becomes the baseline for development, and AI digitalization fully reshapes the logic of industry growth. This year’s conference continues the eleven-year pragmatic tradition, focusing on three core pillars: practicality, implementation, and growth. Centered on key topics such as compliance implementation, AI digital innovation, market transformation, deep patient value cultivation, industry symbiosis, and long-term breakthroughs, it gathers top practitioners across the entire value chain to precisely address industry challenges and unlock new growth pathways.
August 26-28, Shanghai! We cordially invite all pharmaceutical colleagues to gather at the 11th MMC Medical Market Annual Conference. Let us solidify foundations through compliance, empower through innovation, explore new pathways for high-quality industry development, and embark on a new journey of industry value!
Below is the conference agenda outline:
Conference Agenda Outline